Akinsanya Karen

Officer at SDGR

Sold, on record
$7.6M
Dollars the filings state
Form 4 sales
11
Latest Sep 17, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • SDGRSchrodinger, Inc.Officer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SDGRUnusual
    Jun 8, 2021 2021

    Sold 16,721 shares at $75.37 ($1.3M)

    Akinsanya Karen, Officer

    Sold 100% of holdings ($1.3M position)0 shares left1.2x usual sizeFiling

  2. 2 Form 4 sale SDGRUnusual
    Aug 16, 2021 +69 days

    Sold 37,738 shares at $57.74 ($2.2M)

    Akinsanya Karen, Officer

    Sold 100% of holdings ($2.2M position)0 shares left2.5x usual sizeFiling

  3. 3 Form 4 sale SDGRUnusual
    Sep 15, 2021 +30 days

    Sold 1,394 shares at $61.13 ($85k)

    Akinsanya Karen, Officer

    Sold 100% of holdings ($85k position)0 shares left0.1x usual sizeFiling

  4. 4 Form 4 sale SDGRUnusual
    Oct 15, 2021 +30 days

    Sold 1,393 shares at $55.75 ($78k)

    Akinsanya Karen, Officer

    Sold 100% of holdings ($78k position)0 shares left0.1x usual sizeFiling

  5. 5 Form 4 sale SDGRRoutine
    Apr 14, 2025 +1277 days

    Sold 16,723 shares at $25.09 ($420k)

    Akinsanya Karen, President of R&D, Therapeutics

    10b5-1 planSold 51.7% of holdings ($812k position)15,625 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale SDGRRoutine
    Mar 2, 2026 +322 days

    Sold 2,206 shares at $11.99 ($26k)

    Akinsanya Karen, Officer

    10b5-1 planSold 3% of holdings ($882k position)71,322 shares leftFiling

  7. 7 Form 4 sale SDGRRoutine
    Mar 5, 2026 +3 days

    Sold 1,366 shares at $12.90 ($18k)

    Akinsanya Karen, Officer

    10b5-1 planSold 1.9% of holdings ($920k position)69,956 shares leftFiling

  8. 8 Form 4 sale SDGRUnusual
    Sep 17, 2026 +196 days

    Sold 31,599 shares at $29.37 ($928k)

    Akinsanya Karen, Officer

    10b5-1 planSold 31.1% of holdings ($3M position)69,956 shares left14.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Akinsanya Karen
Source
Sep 17, 2026Sep 21, 2026SDGROfficerForm 4 sale31,599$928k31.1%UnusualSEC
Mar 5, 2026Mar 6, 2026SDGROfficerForm 4 sale1,366$18k1.9%RoutineSEC
Mar 2, 2026Mar 3, 2026SDGROfficerForm 4 sale2,206$26k3.0%RoutineSEC
Apr 14, 2025Apr 15, 2025SDGRPresident of R&D, TherapeuticsForm 4 sale16,723$420k51.7%RoutineSEC
Oct 15, 2021Oct 19, 2021SDGROfficerForm 4 sale1,393$78k100.0%UnusualSEC
Sep 15, 2021Sep 16, 2021SDGROfficerForm 4 sale1,394$85k100.0%UnusualSEC
Aug 16, 2021Aug 17, 2021SDGROfficerForm 4 sale37,738$2.2M100.0%UnusualSEC
Jun 8, 2021Jun 9, 2021SDGROfficerForm 4 sale16,721$1.3M100.0%UnusualSEC
Dec 18, 2020Dec 22, 2020SDGROfficerForm 4 sale13,377$1.1M100.0%UnusualSEC
Aug 17, 2020Aug 19, 2020SDGROfficerForm 4 sale3,344$228k100.0%UnusualSEC
Aug 12, 2020Aug 14, 2020SDGROfficerForm 4 sale20,065$1.4M100.0%UnusualSEC